With a rising incidence of cancer cases globally and other lifestyle and chronic diseases, radiation therapy has become pivotal in their treatment. These radiations are used in high doses at regular intervals, to either shrink or kill cancer cells and are categorized into external and internal beam. The external radiations target and treat a part of the patient’s body and is a type of local treatment. However, in case of internal radiation therapy, the source of radiation is inserted in the diseased body.
Even though these radiations significantly aid in treating such diseases, they also have risks associated with them. High dose of radiations absorbed by a body in a short period of time causes radiation sickness, which can have severe impact on the health of a person for a prolonged time. High radiation exposure in hospitals/imaging facilities, is major cause of concern for the stakeholders – the patient/consumer community. Thus, to address these concerns, regulatory bodies in the healthcare industry have released guidelines for management of medical radiation exposure.
According to the recently published market intelligence by BIS Research, titled “Global Radiation Dose Management Market – Analysis and Forecast, 2019-2025”, the radiation dose management market registered a revenue of $217.9 million in 2018. The market is projected to grow at a CAGR of 12.22%, during the forecast period from 2019 to 2025 and reach $484.7 million by 2025.
The growth of the market is supported by the growing geriatric population; increasing prevalence of chronic and lifestyle associated diseases, such as cancer, respiratory diseases, and cardiovascular diseases; increasing number of regulatory requirements for diagnostic devices, rising concerns pertaining to over exposure to radiation, growing awareness toward radiation dose management, and installed bases of radiology equipment and number of scans. However, there are certain limitations that are hampering the growth of the market, including lack of skilled and trained professionals along with lack of benchmarking radiation dose operation.
In addition, several opportunities are present in the market that have the potential to boost the growth of the economy. These include innovations, regulatory forces, regional expansions, and increasing adoption of radiation dose management software in emerging economies. The innovation opportunities also include technological advancement in medical imaging and impact of cloud-based solutions. The regulatory focus of opportunities is specifically on pediatric procedures.
The report by BIS Research highlights that the global radiation dose management market is segmented on the basis of modality, product, mode of deployment, end user, and region. The product segment includes a list of products available in the market, their key features, the compatible modalities, and competitive benchmarking. Some of the products shared in the report include radimetrics enterprise platform, dosewatch, teamplay dose, nexo [dose], tqm/dose, and dosemonitor, radiation dose monitor, imalogix platform, and syncro-dose, among others.
The mode of deployment segment of the market is categorized into competitive benchmarking, web-based, on-premise, and cloud-based. Also, hospitals, diagnostic centers, and others are the sub-segments of the end user segment. The report also includes the data of the radiation dose market related to the five major regions, including North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World (ROW).
Some of the major players operating in the market, include Siemens Healthineers, Inc., Sectra AB, Fujifilm Holdings Corporation, General Electric Company, Bracco, Novarad Corporation, PACSHealth LLC, MyXrayDose, Ltd., and Imalogix.
Request for a Sample of the Report:
https://bisresearch.com/requestsample?id=751&type=download